TenCure - Crunchbase Company Profile & Funding

Q: Where is TenCure's headquarters?

TenCure is located in Jerusalem, Yerushalayim, Israel.

Overview

TenCure

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About TenCure

CB Rank

3300960

TenCure develops personalized oncology therapeutics for epithelial solid tumors including skin, colon and pancreatic cancer.

Founded

obfuscation

Private

Jerusalem, Yerushalayim, Israel

www.tencure.co.il

Biotechnology

Health Care

Health Diagnostics

Medical

Oncology

Key People

Raj Singh: Founder and CMO
Past Role: HEALOR, Founder, CEO

Details

Operating Status

Active

Company Type

For Profit

Founders

Raj Singh

About the Company

TenCure develops personalized oncology therapeutics for epithelial solid tumors including skin, colon and pancreatic cancer. As part of their drug pipeline, they identified a new MOA (Mechanism of Action) by which the insulin signaling pathway affects cancer formation and progression. This explains the marked increased prevalence of cancer in

diabetes and obesity. TenCure’s drug candidates provide the basis for the development of novel cancer therapies addressing various solid cancer indications that are resistant to current treatment modalities. TenCure's technology integrates with the current emerging concept of targeted medicines where personalized treatment regimens are tailored to fit a patient’s tumor-specific characteristics. TenCure was founded in 2012 by Tamar Tennenbaum.